Taken together, these evidences suggest the existence of a pathophysiological interaction between DPP4, endothelial dysfunction, and inflammation, factors that are directly linked to the pathogenesis and clinical manifestations of T2DM and atherosclerosis. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.